更新于 3月19日

(Associate) Director, DMPK Project Rep (MJ012643)

4-6.5万·14薪
  • 北京昌平区
  • 5-10年
  • 博士
  • 全职
  • 招1人

职位描述

生物药新药
  • General Description:
  • The DMPK Department of BeiGene is seeking a highly motivated individual to join the Project Rep group. The successful candidate will have extensive experiences in supporting small as well as large molecule projects with in-depth understanding of how to identify rate-limiting step and impact project team.
  • Serve as a DMPK representative on project teams and collaborate with project team members (e.g., Medicinal Chemistry, Discovery Biology, In vivo Pharmacology, Pre-clinical Safety, Clinical Pharmacology) and groups within DMPK-BA to generate relevant data to support compound progression.
  • Effectively communicate DMPK strategy and knowledge to project teams, functional leaders, and other key stakeholders to ensure alignment and influence decisions
  • Demonstrate thorough understanding of the ADME aspects necessary for the characterization of modalities to support regulatory submissions.
  • Coordinate and request DMPK studies in a timely manner and communicate protocols, timelines, needs and results back to team, ensuring optimized cycle times
  • Mentor junior project reps within the DMPK organization in approaches and best practices, ensuring that support is aligned with project and functional deliverables
  • Additional Job Description
  • Additional Job Description
  • Education Required:
  • A Ph.D. degree in pharmacokinetics, pharmacology, or pharmaceutical sciences with strong project rep experiences


百济神州全球胜任力

当我们通过以下十二项全球胜任力,展现出 "患者为先"、"无界协作"、"锐意创新 "和 "追求卓越 "的价值观时,我们就能帮助全世界更多患者获得更多负担得起的药品。

• 团队协作

• 提供并征求坦诚及可行的反馈

• 自我认知

• 兼容并蓄

• 积极主动

• 开拓精神

• 持续学习

• 拥抱变化

• 结果导向

• 分析性思维/数据分析

• 卓越财务

• 清晰沟通


BeiGene Global Competencies

When we exhibit our values of Patients First, Collaborative Spirit, Bold Ingenuity and Driving Excellence, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.

• Fosters Teamwork

• Provides and Solicits Honest and Actionable Feedback

• Self-Awareness

• Acts Inclusively

• Demonstrates Initiative

• Entrepreneurial Mindset

• Continuous Learning

• Embraces Change

• Results-Oriented

• Analytical Thinking/Data Analysis

• Financial Excellence

• Communicates with Clarity


求职者隐私申明:

百济神州致力于尊重和保护您的个人信息权利,并承诺依据合法、正当、必要和诚信的原则处理您的个人信息(包括个人敏感信息 )。

由于百济神州在全球范围内开展业务,我们可能需要基于人力资源管理等合理业务目的而将您的个人信息发送和/或存储在位于您所在国家以外其他国家(例如:美国)的服务器和数据库中,详情参见百济神州《求职者隐私政策》(百济神州官网 - 隐私政策 - 求职者隐私政策)。

如您主动向我们提供您的简历信息或其他个人信息,则视为您已经充分理解并确认接受百济神州《求职者隐私政策》内容。如您对此有任何疑问的,请勿提交简历信息或其他个人信息。


BeiGene is committed to respect and protect your personal information rights, and will process your personal information, including your sensitive personal information, based on the principles of legality, legitimacy, necessity, and integrity.

Due to the reasonable business need for human resource management as a result of BeiGene’s global operation, your personal information may be transferred and/ or stored in a server/database located in a third country (e.g., the United States) other than your own country. For further details, please refer to BeiGene Job Applicant Privacy Policy (BeiGene official website - Privacy Policy - Job Applicant Privacy Policy).

If you voluntarily provide your resume or other personal information to us, it is deemed as you have thoroughly acknowledged and accepted BeiGene Job Applicant Privacy Policy. If you have any concern, please DO NOT submit your resume or any other personal information.

工作地点

北京市昌平区科学园路30号
以担保或任何理由索要财物,扣押证照,均涉嫌违法。一经发现,

职位发布者

张婧媛/人事经理

昨日活跃
立即沟通
百济神州北京
About BeiGene BeiGene is a publically traded(BGNE, NASDAQ), globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer. Our cancer biology platform addresses the importance of tumor-immune system interactions and the value of primary tumor biopsies in developing new cancer models. We have a global team of over 200 individuals, including over 150 scientists and clinicians, and a world-renowned scientific advisory board, with deep scientific talent, extensive pharmaceutical experience, and a commitment to improving the lives of cancer patients around the world. Our clinical pipeline is comprised of novel oral small molecules and monoclonal antibodies(mAb) for cancer, including an anti-PD-1 monoclonal antibody, a best-in-class BTK inhibitor, a RAF dimer inhibitor, a best-in-class PARP inhibitor, and a variety of combination clinical studies. In addition, our robust preclinical programs are expected to generate more small molecule and mAb drugs for clinical development in coming years. For more information, please visit our website at www.beigene.com.
公司主页

上智联,你更值3.74亿+ 职场人的选择 780万+ 高新职位精准推荐